Asuka Kawachi

Chuo, 1040045, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Durable tumor control with stereotactic radiotherapy and doxorubucin-ifosfamide chemotherapy in primary intracranial sarcoma, DICER1-mutant: a case report.

Durable tumor control with stereotactic radiotherapy and doxorubucin-ifosfamide chemotherapy in primary intracranial sarcoma, DICER1-mutant: a case report.

Journal: International cancer conference journal

Published: December 12, 2025

Dual compartment utility of BRET-based biosensors for PPP2R5A/B56α, a cancer-associated B regulatory subunit of PP2A.

Dual compartment utility of BRET-based biosensors for PPP2R5A/B56α, a cancer-associated B regulatory subunit of PP2A.

Journal: BioTechniques

Published: June 28, 2025

Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancer.

Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancer.

Journal: Breast cancer (Tokyo, Japan)

Published: April 19, 2025

The Impact of Splicing Factor Mutations on Clonal Hematopoiesis and Myeloid Neoplasm Progression.

The Impact of Splicing Factor Mutations on Clonal Hematopoiesis and Myeloid Neoplasm Progression.

Journal: Frontiers in bioscience (Landmark edition)

Published: March 05, 2025

Treatment and Reasons for Choosing Treatment in Breast Cancer Patients Who Underwent Next-Generation Sequencing Test.

Treatment and Reasons for Choosing Treatment in Breast Cancer Patients Who Underwent Next-Generation Sequencing Test.

Journal: Oncology

Published: October 24, 2024

Efficacy of Eribulin Monotherapy in Patients With Unresectable and/or Metastatic Adenoid Cystic Carcinoma Receiving Platinum-Based Therapy.

Efficacy of Eribulin Monotherapy in Patients With Unresectable and/or Metastatic Adenoid Cystic Carcinoma Receiving Platinum-Based Therapy.

Journal: Head & neck

Published: September 13, 2024

Hemangiosarcoma in dogs as a potential non-rodent animal model for drug discovery research of angiosarcoma in humans.

Hemangiosarcoma in dogs as a potential non-rodent animal model for drug discovery research of angiosarcoma in humans.

Journal: Frontiers in oncology

Published: June 30, 2023

Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer.

Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer.

Journal: Frontiers in oncology

Published: February 03, 2023

Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy.

Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy.

Journal: Scientific reports

Published: December 20, 2022

Pathogenic Roles of RNA-Binding Proteins in Sarcomas.

Pathogenic Roles of RNA-Binding Proteins in Sarcomas.

Journal: Cancers

Published: July 13, 2022

Systematic identification of intron retention associated variants from massive publicly available transcriptome sequencing data.

Systematic identification of intron retention associated variants from massive publicly available transcriptome sequencing data.

Journal: Nature communications

Published: October 21, 2021

First-line treatment for lung cancer among Japanese older patients: A real-world analysis of hospital-based cancer registry data.

First-line treatment for lung cancer among Japanese older patients: A real-world analysis of hospital-based cancer registry data.

Journal: PloS one

Published: December 22, 2020

Showing 1-12 of 25

Last Updated: 09/26/2026